Wei-Chi Wu

473 total citations
31 papers, 260 citations indexed

About

Wei-Chi Wu is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Wei-Chi Wu has authored 31 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 12 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Wei-Chi Wu's work include Retinal and Optic Conditions (6 papers), Ocular Diseases and Behçet’s Syndrome (5 papers) and Retinal Diseases and Treatments (4 papers). Wei-Chi Wu is often cited by papers focused on Retinal and Optic Conditions (6 papers), Ocular Diseases and Behçet’s Syndrome (5 papers) and Retinal Diseases and Treatments (4 papers). Wei-Chi Wu collaborates with scholars based in Taiwan, United States and China. Wei-Chi Wu's co-authors include Chi‐Chun Lai, Zhihui Yü, Jing Wang, Zhongping Chen, Xiaoqiang Sun, Shaoyan Xi, Jinyu Cheng, Ling Yeung, Nan‐Kai Wang and Yih‐Shiou Hwang and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Science Advances.

In The Last Decade

Wei-Chi Wu

24 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei-Chi Wu Taiwan 9 81 71 71 45 42 31 260
Alfonso D’Ambrosio Italy 7 83 1.0× 88 1.2× 13 0.2× 28 0.6× 28 0.7× 19 224
Dallas Shi United States 10 162 2.0× 119 1.7× 58 0.8× 7 0.2× 65 1.5× 12 395
Ashwini Kini United States 7 106 1.3× 64 0.9× 33 0.5× 13 0.3× 16 0.4× 37 247
Xiang Q. Werdich United States 11 114 1.4× 131 1.8× 16 0.2× 10 0.2× 83 2.0× 16 326
Siming Ai China 11 61 0.8× 67 0.9× 31 0.4× 5 0.1× 11 0.3× 25 225
Saori Yaguchi Japan 13 145 1.8× 144 2.0× 33 0.5× 10 0.2× 206 4.9× 22 496
Jing Sima China 6 141 1.7× 102 1.4× 14 0.2× 25 0.6× 238 5.7× 10 371
Sebastian E. Koschade Germany 10 54 0.7× 188 2.6× 24 0.3× 15 0.3× 44 1.0× 24 328
BE DAMATO United Kingdom 8 224 2.8× 87 1.2× 35 0.5× 7 0.2× 103 2.5× 20 359
Elina Rantala Finland 8 223 2.8× 81 1.1× 87 1.2× 3 0.1× 48 1.1× 12 304

Countries citing papers authored by Wei-Chi Wu

Since Specialization
Citations

This map shows the geographic impact of Wei-Chi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Chi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Chi Wu more than expected).

Fields of papers citing papers by Wei-Chi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Chi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Chi Wu. The network helps show where Wei-Chi Wu may publish in the future.

Co-authorship network of co-authors of Wei-Chi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Chi Wu. A scholar is included among the top collaborators of Wei-Chi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Chi Wu. Wei-Chi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Mei, Muhammad Faizan, Chi‐Hsien Liu, et al.. (2025). Sustainable electrochemical biosensor using polyol-protected probes and magnetic MOFs for thermally robust coronavirus gene detection. Green Analytical Chemistry. 16. 100317–100317.
3.
Vinekar, Anand, Wei-Chi Wu, Birgit Lorenz, et al.. (2025). Rare pediatric retinal diseases: A review. Indian Journal of Ophthalmology. 73(5). 622–636.
4.
Liu, Chi‐Hsien, et al.. (2024). A novel eco-friendly electrochemical fabrication of magnetic bimetallic-organic framework sensors for ultrasensitive detection of dual miRNAs. Journal of environmental chemical engineering. 13(1). 115265–115265. 7 indexed citations
5.
Chen, Yen‐Ting, Chi‐Chun Lai, Yih‐Shiou Hwang, Kuan‐Jen Chen, & Wei-Chi Wu. (2024). A Surgical Approach for Managing Refractory Macular Holes Using the Human Amniotic Membrane Patch Technique. Ophthalmic surgery, lasers & imaging retina. 55(10). 613–616. 2 indexed citations
6.
Wu, Wei-Chi, Wei‐Chih Chin, Shih‐Chieh Hsu, et al.. (2024). Relations between Neurocognitive Function and Visual Acuity: A Cross-Sessional Study in a Cohort of Premature Children. Children. 11(8). 894–894.
7.
Dave, Vivek Pravin, Hung‐Da Chou, Şengül Özdek, et al.. (2023). Retinotomies and retinectomies: A review of indications, techniques, results, and complications. Survey of Ophthalmology. 68(6). 1038–1049. 3 indexed citations
8.
Kang, Eugene Yu‐Chuan, Shih‐Chieh Shao, Edward Chia‐Cheng Lai, et al.. (2023). Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Diabetes & Metabolism Journal. 47(3). 394–404. 26 indexed citations
9.
Kozak, Igor, Syed Abid Ali, & Wei-Chi Wu. (2022). Novel retinal observations in a child with DiGeorge (22q11.2 deletion) syndrome. American Journal of Ophthalmology Case Reports. 27. 101608–101608. 2 indexed citations
10.
Kang, Eugene Yu‐Chuan, et al.. (2022). A rare case of bilateral vitreoretinopathy of Aicardi syndrome. American Journal of Ophthalmology Case Reports. 26. 101467–101467.
11.
Guo, Chengcheng, Zhihui Yü, Wei-Chi Wu, et al.. (2020). Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma. Cancer Chemotherapy and Pharmacology. 86(6). 773–782. 22 indexed citations
12.
13.
Kang, Eugene Yu‐Chuan, Nan‐Kai Wang, Ling Yeung, et al.. (2019). Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan. BMJ Open. 9(2). e025455–e025455. 16 indexed citations
14.
Lee, Chia‐Yi, Hung‐Chi Chen, Yaa‐Jyuhn James Meir, David Hui‐Kang, & Wei-Chi Wu. (2017). Subconjunctival injection of bevacizumab for recurrent conjunctival papilloma: a case report. Canadian Journal of Ophthalmology. 52(5). e156–e159. 3 indexed citations
15.
Chen, Yi‐Hsing, Ming‐Hui Sun, Shao‐Hsuan Hsia, Chi‐Chun Lai, & Wei-Chi Wu. (2014). Rare ocular features in a case of Kabuki syndrome (Niikawa-Kuroki syndrome). BMC Ophthalmology. 14(1). 143–143. 17 indexed citations
16.
Wu, Wei-Chi, Chia-Pang Shih, Nan‐Kai Wang, et al.. (2013). Choroidal Thickness in Patients With a History of Retinopathy of Prematurity. JAMA Ophthalmology. 131(11). 1451–1451. 3 indexed citations
17.
Kao, Ling-Yuh, et al.. (2013). MULTIMODAL RETINAL IMAGING IN ACHROMATOPSIA. Retinal Cases & Brief Reports. 8(1). 1–3. 1 indexed citations
18.
Kuo, Jane Z., Frank S Ong, Ling Yeung, et al.. (2011). PREDICTIVE FACTORS FOR VISUAL OUTCOME TO INTRAVITREAL BEVACIZUMAB IN YOUNG CHINESE PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION. Retina. 31(9). 1835–1840. 18 indexed citations
19.
Wu, Wei-Chi, et al.. (2010). Autosomal dominant multiple syringomas linked to chromosome 16q22. British Journal of Dermatology. 162(5). 1083–1087. 9 indexed citations
20.
Wu, Wei-Chi, et al.. (1994). Demonstration of a Double-Stranded DNA-Stimulated Protein-Kinase (DNA-PK) Inhibitory Activity in Human HL-60 Leukemia Cells. Biochemical and Biophysical Research Communications. 202(3). 1530–1537. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026